An­oth­er Flag­ship-found­ed biotech shut­ters as Ax­cel­la liq­ui­dates, end­ing long Covid plans

An­oth­er Flag­ship Pi­o­neer­ing-found­ed biotech will shut­ter, as 12-year-old Ax­cel­la dis­closed that its stock­hold­ers over­whelm­ing­ly ap­proved its dis­so­lu­tion and liq­ui­da­tion on Mon­day, per an SEC …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER